GeneDx (WGS) closed at $63.61 on Oct 16, 2026, down 9.4% on the day. The stock is down 39.4% over the past month, up 4.9% over three months, down 51.1% year to date and down 45.6% over the past year. It trades 62.8% below its 52-week high of $170.87 and 97.5% above its 52-week low of $32.21. The close sits below its 50-day moving average ($81.77) and below its 200-day moving average ($75.01).
NextPick tracks WGS in its Genomics basket alongside ILMN, TWST, TXG and PACB. As of Oct 16, 2026, the basket's money-flow score is -27 (weak outflow), and the basket is down 13.4% over five sessions. Over the past month WGS ranks 5th of 5 basket members by price change.
WGS is scheduled to report earnings on Oct 26, 2026. Over its last 8 reports the stock moved an average of 26.7% on the first trading day after earnings, beating the options-implied move in 4 of 8.
WGS options were pricing 114% at-the-money implied volatility on Oct 13, 2026, an IV rank of 72 over the past year.
GeneDx is scheduled to report on Oct 26, 2026.
Over the last 8 reports, WGS moved an average of 26.7% on the first trading day after earnings. The move beat the options-implied move in 4 of 8 reports.
No — the Oct 16, 2026 close of $63.61 is 15.2% below the 200-day average of $75.01.
WGS closed 62.8% below its 52-week high of $170.87.
NextPick groups WGS with ILMN, TWST, TXG and PACB in its Genomics basket.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
